Expression of protease activated receptor-2 in human colorectal cancer and its association with tumor progression

Diseases of the Colon and Rectum

Volumn 53, Issue 8, 2010, Pages 1202-1208

  Chang, Jae Hyuck ^a   Park, Jae Myung ^a   Kim, Sang Woo ^a   Jung, Chan Kwon ^a   Kang, Won Kyung ^a   Oh, Seong Taek ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Colorectal cancer; Immunohistochemistry; Microarray analysis; Neoplasm invasiveness; Protease activated receptor 2

Indexed keywords

ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 2 ANTIBODY; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KOREA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL; TUMOR GROWTH; TUMOR LOCALIZATION; BIOSYNTHESIS; CELL PROLIFERATION; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE COURSE; ENZYMOLOGY; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE; TIME;

CELL PROLIFERATION; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KOREA; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, PAR-2; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956212804     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181d536f6     Document Type: Article

References (31)

1. Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer. 2001;85:772-779.
2. Vergnolle N. Clinical relevance of proteinase activated receptors (pars) in the gut. Gut. 2005;54:867-874.
3. Yamamoto H, Iku S, Adachi Y, et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol. 2003;199:176-184.
4. Miyata S, Koshikawa N, Yasumitsu H, Miyazaki K. Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2. J Biol Chem. 2000;275:4592-4598.
5. Shibata K, Yada K, Matsumoto T, et al. Protease-activating-receptor- 2 is frequently expressed in papillary adenocarcinoma of the gallbladder. Oncol Rep. 2004;12:1013-1016.
6. Fujimoto D, Hirono Y, Goi T, et al. Expression of protease activated receptor-2 (PAR-2) in gastric cancer. J Surg Oncol. 2006; 93:139-144.
7. Li Z, Bian LJ, Li Y, Liang YJ, Liang HZ. Expression of proteaseactivated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: Correlation with clinicopathological features and prognosis. Pathol Res Pract. 2009;205:542-550.
8. Greene FL, American Joint Committee on Cancer. American Cancer Society. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
9. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell. 1991;64:327-336.
10. Gregoire M, Lieubeau B. The role of fibroblasts in tumor behavior. Cancer Metastasis Rev. 1995;14:339-350.
11. Oyama K, Ohta T, Nishimura GI, et al. Trypsinogen expression in colorectal cancers. Int J Mol Med. 2000;6:543-548.
12. Soreide K, Janssen EA, Korner H, Baak JP. Trypsin in colorectal cancer: Molecular biological mechanisms of proliferation, invasion, and metastasis. J Pathol. 2006;209:147-156.
13. Williams SJ, Gotley DC, Antalis TM. Human trypsinogen in colorectal cancer. Int J Cancer. 2001;93:67-73.
14. Solakidi S, Tiniakos DG, Petraki K, et al. Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas. Histol Histopathol. 2003;18: 1181-1188.
15. Bohm SK, Kong W, Bromme D, et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J. 1996;314(Pt 3):1009-1016.
16. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A. 1994;91:9208-9212.
17. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinaseactivated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol. 1998;274:C1429-C1452.
18. Morris DR, Ding Y, Ricks TK, et al. Protease-activated receptor- 2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res. 2006;66: 307-314.
19. Caruso R, Pallone F, Fina D, et al. Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol. 2006;169:268-278.
20. Ohta T, Shimizu K, Yi S, et al. Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers. Int J Oncol. 2003;23:61-66.
21. Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol. 2001;70:255-264.
22. Rimm DL, Camp RL, Charette LA, et al. Tissue microarray: A new technology for amplification of tissue resources. Cancer J. 2001;7:24-31.
23. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
24. Skacel M, Skilton B, Pettay JD, Tubbs RR. Tissue microarrays: A powerful tool for high-throughput analysis of clinical specimens: A review of the method with validation data. Appl Immunohistochem Mol Morphol. 2002;10:1-6.
25. Rassidakis GZ, Jones D, Thomaides A, et al. Apoptotic rate in peripheral T-cell lymphomas: A study using a tissue microarray with validation on full tissue sections. Am J Clin Pathol. 2002; 118:328-334.
26. Gulmann C, Butler D, Kay E, Grace A, Leader M. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology. 2003;42:70-76.
27. Griffin MC, Robinson RA, Trask DK. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx. Mod Pathol. 2003;16:1181-1188.
28. Leversha MA, Fielding P, Watson S, Gosney JR, Field JK. Expression of p53, pRB, and p16 in lung tumours: A validation study on tissue microarrays. J Pathol. 2003;200:610-619.
29. Darmoul D, Gratio V, Devaud H, Lehy T, Laburthe M. Aberrant expression and activation of the thrombin receptor proteaseactivated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol. 2003;162:1503-1513.
30. Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM. Proteaseactivated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res. 2004;2:395-402.
31. Nishibori M, Mori S, Takahashi HK. Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell. J Pharmacol Sci. 2005;97: 25-30.